1. Market Research
  2. > Healthcare Market Trends
  3. > General Medicine and Specialty Medicine

General & Specialty Medicine Market: Get Industry Insights

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
13 votes

Global General & Specialty Medicine

The general and specialty medecine industry is one level down from the section dedicated to the healthcare sector.

General medicine is concerned with treating chronic and acute diseases through preventive care, curative care and health education. In comparison, specialty medicine involves the treatment of specific medical conditions and illnesses. Major specialties within this branch of medicine include therapeutic, diagnostic, internal and surgical medicine.

Key Market Segments                                                       

The worldwide market for pain management therapeutics was worth almost $20 billion in 2010, according to GBI Research. The market recorded yearly growth in excess of 5% for the eight-year period ending 2010. Lyrica, an anticonvulsant, and Cymbalta, an anti-depressant, represent the leading products on the pain management market. Both are due to expire in 2013. The global pain management therapeutics industry is expected to record yearly growth of 3% between 2010 and 2017 to exceed $35 billion. Market leaders that will continue to fuel market growth include Pfizer’s Remoxy, UCB Group’s Vimpat, J&J’s Nucynta, Orexo’s Abstral and Teva’s Fentora.

Leading markets within the pain management therapeutics industry include post-operative pain, low-back pain and cancer pain relief markets. Post-operative pain relief represents the largest segment, reaching almost $6 billion in 2010 or 20% of the overall industry. The post-operative pain relief market was followed by the low-back pain market, which reached almost $5 billion in 2010, for more than 15% of the overall pain management therapeutics market. The cancer pain and neuropathic pain relief markets came third, accounting for a slightly lower percentage of the overall industry than the low-back pain market.

The global dermatology market is lead by demand for psoriasis treatment. There are less than 20 million sufferers worldwide, but it accounts for close to 20% of the overall dermatology market, reports Business Insights. The anti-acne market segment is fuelled by combination products, with leading products including Ziana by Medicis, Duac by GSK/Stiefel, and Sanofi’s BenzaClin. Dermatology sales generated $1.3 billion for leading company Leo Pharma in 2010, representing 20% year-on-year growth. The company is forecast to continue recording strong sales with the launch of its actinic keratosis treatment ingenol mebutate.

Sports medicine continues to benefit from technological developments. Arthroscopy, a minimally invasive technique has shortened recovery time for athletes. Most procedures are carried out to repair knee damage, reports Koncept Analytics. Sports-related injuries continue to rise due to changing lifestyles, and a growing interest in health and fitness. A higher demand for sports medicine also comes into play thanks to the world’s aging population and less-invasive arthroscopic surgery techniques. The greatest share of profit within sports medicine is derived from shoulder and knee treatments, with arthroscopic repairs marking the market segment with the fastest rate of growth. The US dominates the arthroscopic market, with Smith & Nephew remaining the leading company operating in the market. Other key companies include ArthroCare, Stryker, Conmed, DePuy Mitek and Arthrex.

Regional Market Share

The emerging nations of China, Russia, South Africa, Brazil and India hold immense potential for the general and specialty medical industry due to a significant number of patients whose needs are not currently being met. According to Global Data, there are over 120 million people aged 65 or older living in China. In India, more than a billion people, or 5% of the overall population, fall into this category. The country’s population is set to outpace that of China in around 20 years, which will make it the world’s most-densely populated nation. Healthcare demand is, therefore, set to continue rising at a high rate.

In Europe, facial aesthetics, medical laser devices and cosmetic surgery generated close to $660 million in 2010, according to research from iData Research. The market is expected to grow to $1.3 billion by 2017.

Read more »

24/7 Customer Support

Talk to Sam

+33 4 37 65 17 06

12 Reports
Demographic, Supply, Demand
4 Statistics
Market Size, Demand, Finance
3 Reports
Demographic, Supply, Company Financials
15 Reports
Company, Company Financials, Market Size
31 Statistics
Market Size, Demand, Company
52 Reports
Demographic, Company, Supply
160 Statistics
Market Size, Demand, Demographic
3 Reports
Company, Company Financials, Market Size
8 Statistics
Demand, Market Size, Finance
26 Reports
Demographic, Supply, Demand
400 Statistics
Demographic, Supply, Environment
7 Reports
Demographic, Company, Company Financials
24 Statistics
Demographic, Demographic Indicators, Environment
4 Reports
Demographic, Supply, Company Financials
21 Statistics
Demographic, Environment, Market Size
4 Reports
Supply, Forecast, Company
36 Statistics
Demand, Market Size, Finance
3 Reports
Demographic, Company Financials, Demand
27 Statistics
Demographic, Demographic Indicators, Environment
Search in General Medicine And Specialty Medicine Industry (About 700 reports)
Parent industry: Healthcare
Related industries: Diagnostics, Alternative Medicine, Managed Care, Health Services, Veterinary Healthcare, Medical Device, Medical Supply, Pathology, Health Insurance, E-Healthcare

About 700 reports

Purchase Reports From Reputable Market Research Publishers
(From € 455 - € 9995)

Vascular Graft Market by Indication, Raw Material, End Users - Global Forecast to 2022

Vascular Graft Market: Global Forecast until 2022

  • € 5045
  • Industry report
  • January 2018
  • by MarketsandMarkets

Global vascular grafts market projected to grow at a CAGR of 7.3% during the forecast periodThe vascular grafts market is expected to reach USD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a ...

Lung Cancer Surgery Market: Global Forecast until 2021 € 5045 January 2017

Thrombectomy Devices Industry: Forecasts to 2022 € 5268 September 2017

Vascular Graft Industry: Forecasts to 2024 € 5268 May 2017

Interventional Oncology Sector: Worldwide Forecast unti ... € 2427 March 2017

Hematopoietic Stem Cell Transplantation Industry: Forec ... € 5268 May 2017

Organ Preservation Sector: Worldwide Forecast until 202 ... € 2427 November 2017

Oncology Information System Industry: Forecasts to 2022 € 5268 October 2017

Lumpectomy Sector: Forecast until 2022 in the US € 3398 February 2018

Lumpectomy Sector: Forecast until 2021 in Europe € 2427 March 2017


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on